Understanding Manufacturer Information
Manufacturer information is an important part of responsible medicine identification. A medicine website should distinguish between the company that developed an active ingredient, the company that manufactures a particular commercial product, the brand owner, the marketing authorization holder and the distributor.
For the products listed on this website, the supplied product brief identifies:
| Generic | Brand | Strength | Company listed |
|---|---|---|---|
| Baricitinib | Barinib | 2 mg | General |
| Baricitinib | Barigen | 4 mg | General |
The term General is reproduced from the supplied product information. It should not be interpreted as proof of a specific pharmaceutical manufacturing company.
Reference Product
The established reference brand for baricitinib is Olumiant. Current U.S. DailyMed information identifies Olumiant as a baricitinib tablet product and lists Eli Lilly and Company as the packager.
The European Medicines Agency identifies Eli Lilly Nederland B.V. as the marketing authorization holder for Olumiant in the European Union.
This information concerns Olumiant and should not automatically be transferred to Barinib or Barigen.
Developer Versus Manufacturer
A pharmaceutical company can have several different roles.
The developer is involved in discovering and developing a medicine.
The manufacturer is responsible for producing a specific medicinal product or one or more stages of its manufacture.
The marketing authorization holder is legally responsible for a medicinal product’s authorization in a particular jurisdiction.
A distributor may be responsible for moving products through the supply chain.
A supplier may provide the product to a pharmacy, hospital or other purchaser.
These roles may belong to different organizations.
Why Product Identity Matters
Patients should be able to determine what medicine they have received. Packaging should normally identify important information such as:
- Product name
- Active ingredient
- Strength
- Dosage form
- Manufacturer or responsible company
- Batch or lot number
- Expiry date
- Storage requirements
- Regulatory information where applicable
If a package does not match the expected information, professional advice should be sought before use.
Brand and Generic Relationship
Barinib and Barigen are commercial names identified in the supplied brief for products containing baricitinib. The generic substance is baricitinib.
The generic name describes the active pharmaceutical ingredient. The brand name identifies a particular marketed product.
Two products containing the same active ingredient should not automatically be described as identical in every respect. They may have different manufacturers, excipients, packaging, authorization pathways and supply chains.
Why Verification Is Important
Manufacturer information becomes especially important when purchasing prescription medicines through international supply channels. Product identity should be checked against the physical packaging and appropriate regulatory information.
A website should never state that a product is authentic solely because a customer provides a photograph or because a package contains a barcode, serial number or QR code.
Quality and Regulatory Status
Quality claims should be supported by appropriate documentation. Statements about manufacturing facilities, certifications, regulatory approvals or pharmaceutical awards should not be published without reliable evidence.
For Barinib and Barigen, the supplied brief provides the commercial names and strengths but does not independently establish detailed manufacturer credentials.
Responsible Product Information
The purpose of manufacturer information on this website is transparency rather than promotion. No listed company should be presented as medically superior to another company merely because its product contains baricitinib.
The most important considerations are correct product identity, lawful authorization, appropriate quality standards and safe use under professional guidance.